Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.

Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.

The Scientist looks at one such Houston-based purveyor that has been treating patients abroad for years with mesenchymal stem cells.

Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 

Adding or removing water changes how stem cells differentiate.

The technique, demonstrated in mice using engineered mesenchymal stem cells, has potential for both diagnosis and treatment.

These engineered “cells” were made from the secretions and membranes of human mesenchymal stem cells.

See researchers' recipe for synthetic mesenchymal stem cells, which showed cardiac regenerative potential in mice.

Paolo Bianco crusaded against cell therapy fraud and hype.

Researchers show organoids grown from human stem cells can excrete urine when implanted in rats and pigs.

A decade of research on intercellular mitochondrial transfer has answered some long-standing questions and raised new ones.

A screen of 9,000 small molecules identifies a treatment that improves the targeting of mesenchymal stem cells to sites of damaged tissue.

Second review of a controversial stem cell trial in Italy has reached the same conclusion: it’s a no-go.

Scientists generate a new crop of stem cells that show therapeutic potential in mouse models of autoimmune diseases.

The stiffness of a culture substrate affects the fates of stem cells.  

The topography of a stem cell’s environment can influence cilia length, which in turn modulates cell signaling and development.

A new working group is seeking to define rigorous standards for the study of mesenchymal stem cells.